CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 63 enrolled
Drug / intervention
Thoracic paravertebral block +1 morecombination
Likely dose
Thoracic paravertebral block 0.05mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04482192
NCT04482192Phase 3Completed
CompareCT.gov

Continuous Paravertebral Block by Intraoperative Direct Access Versus Systemic Analgesia for Postthoracotomy Pain Relief

Zagazig University·interventional·Posted Jul 22, 2020·Updated Jul 23, 2020

In Brief

A Phase 3 clinical trial evaluating Thoracic paravertebral block and Systemic analgesia for Post Thoracotomy Pain. Completed, enrolled 63 participants.

Detailed Summary

to evaluate the safety and efficacy of continuous paravertebral block by intraoperative direct access on postthoracotomy pain compared to systemic analgesia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost Thoracotomy Pain
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 22, 2020
Enrollment StartJun 15, 2015
Primary CompletionJan 31, 2020
Study CompletionMar 31, 2020
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 5.9 years ago

Interventions

Thoracic paravertebral blockcombination

After ending pulmonary procedure, a pleural pouch created beside vertebral column, a catheter is inserted to the pouch for continuous infusion of 1% lidocaine for 3 postoperative days. Intravenous morphine sulfate (0.05mg/kg) was given as a rescue medication if the VAS ≥ 4.

Systemic analgesiadrug

Systemic analgesia (SA) group receive 1gm paracetamol and 30 mg ketorolac by intravenous infusion every 6 hours for 3 days. Intravenous morphine sulfate (0.05mg/kg) was given as a rescue medication if the VAS ≥ 4.